AstraZeneca Group plc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (48)

Latest Posts

About This Stock More About This Stock
AstraZeneca: 4% Dividend Yield And A Pipeline To Emerging Market Growth
Article By: SureDividend
Thursday, June 15, 2017 11:35 AM EDT
AstraZeneca’s strong pipeline and heavy presence in the emerging markets lay the groundwork for future growth.
In this article: AZN Also: JNJ, ABT
AstraZeneca Enters Agreement With Grunenthal To Divest Rights To Zomig
Article By: The Fly
Wednesday, June 7, 2017 12:10 PM EDT
AstraZeneca announced that it has entered an agreement with Grunenthal for the global rights to Zomig outside Japan.
In this article: AZN, IPXL
Week In Review: Shanghai Pharma Considers $4 Billion Bid For Germany's Stada
Article By: ChinaBio® Today
Saturday, May 20, 2017 11:46 AM EDT
Shanghai Pharma may bid $4 billion to acquire Stada Arzneimittel, a German generic drugmaker. Stada has already accepted a similar offer from a consortium formed by two private equity firms -- Bain and Cinven.
In this article: AZN, LLY
E AstraZeneca Achieves Positive Phase 3 Results In Late Stage Cancer Trial
Article By: Terry Chrisomalis
Sunday, May 14, 2017 3:52 AM EDT
On Friday, AstraZeneca announced that it had achieved positive results in a phase 3 lung cancer study. The key drug used in the trial, Imfinzi, was shown to greatly cut the risk of death in lung cancer patients.
In this article: AZN Also: MRK
18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma
Article By: Lorimer Wilson
Saturday, April 22, 2017 8:24 PM EDT
With 18 branded drugs on the line, patent losses this year could jeopardize $26.5 billion in annual sales from Big Pharma, projected to be the biggest fall-off until at least 2025.
In this article: AZN, BMY, GSK, LLY, MRK, PFE, SNY, RHHBY, TEVA


Latest Tweets for $AZN

No tweets yet!